Analysis of genetic variants in cardiovascular risk genes by heteroduplex analysis
A Cenarro1, F Civeira, M Pocovi
1Department of Biochemistry and Cellular Molecular Biology, University of Zaragoza, Zaragoza, Spain.
Abstract:
As an increasing number of human diseases are linked to the effects of altered genes, new methods are being sought for detection of mutations and their relationship to the presence of disease. Since total genomic DNA usually cannot be analyzed directly, target sequences are amplified by the polymerase chain reaction (PCR). Several methods have been reported that allow detection of small changes in DNA sequence (1). Among them, one of the most commonly used is the heteroduplex analysis method (HA) (2-5).
More Related Videos
Related Concept Videos
Principles of Pharmacogenetics: Types of Genetic Variants
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenomics: Identification of New Drug Targets
Genetic Variation
Genes exist in different versions called alleles, which...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...


